SINOPHARM GROUP CO LTD ADR

Price Chart

Risk-Adjusted Performance

Also Listed On

SINOPHARM GROUP CO LTD ADR (SHTDY) Price Performance

SINOPHARM GROUP CO LTD ADR (SHTDY) trades on United States in USD. The company is classified in the Healthcare sector under the Medical Distribution industry. The stock currently trades at $13.22, up 0.08% from the previous close.

Over the past year, SHTDY has traded between a low of $10.57 and a high of $14.06. The stock has gained 16.6% over this period. It is currently 6.0% below its 52-week high.

SINOPHARM GROUP CO LTD ADR has a market capitalization of $8.29B and a dividend yield of 355.00%.

About SINOPHARM GROUP CO LTD ADR

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices Distribution segment distributes medical devices, as well as provides installation and maintenance services. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the distribution of laboratory supplies; manufacture and distribution of chemical reagents; and production and sale of pharmaceutical products. The company rents and manages properties; distributes medical instruments and equipment, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. It also manages medical project investment, consulting, and technology training activities; and manufactures medicines. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.